EISAI CO

EISAI CO logo
πŸ‡―πŸ‡΅Japan
Ownership
Public
Established
1941-12-06
Employees
11K
Market Cap
$12B
Website
http://www.eisai.co.jp

E2022 Patch Formulation Single Dose Phase I Study

Phase 1
Completed
Conditions
Interventions
First Posted Date
2010-12-03
Last Posted Date
2013-05-14
Lead Sponsor
Eisai Co., Ltd.
Target Recruit Count
80
Registration Number
NCT01253434

Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Clinical Safety and Effectiveness in Patients With Alzheimer's Disease

Completed
Conditions
Interventions
First Posted Date
2010-12-02
Last Posted Date
2023-07-24
Lead Sponsor
Eisai Co., Ltd.
Target Recruit Count
894
Registration Number
NCT01251718

An Study of Efficacy and Safety of Clevudine

Phase 3
Completed
Conditions
Interventions
First Posted Date
2010-09-01
Last Posted Date
2013-05-14
Lead Sponsor
Eisai Co., Ltd.
Target Recruit Count
288
Registration Number
NCT01192854
Locations
πŸ‡¨πŸ‡³

Xiangya hospital, Changsha, Hunan, China

Safety and Efficacy of Mecobalamin Injection in Peripheral Neuropathies Patients (Study JGAZSY091109)

First Posted Date
2010-08-31
Last Posted Date
2012-11-07
Lead Sponsor
Eisai Co., Ltd.
Target Recruit Count
1072
Registration Number
NCT01192113
Locations
πŸ‡¨πŸ‡³

the 2nd Hospital of Suzhou University, Suzhou, Jiangsu, China

πŸ‡¨πŸ‡³

Subei People Hospital, Yangzhou, Jiangsu, China

πŸ‡¨πŸ‡³

The 1st People Hospital of Yangzhou, Yangzhou, Jiangsu, China

and more 20 locations

Efficacy and Safety of Teprenone in Patients With Acute Gastritis, Acute Gastric Lesion of Chronic Gastritis With Acute Exacerbation or Gastric Ulcer

Phase 4
Completed
Conditions
Interventions
First Posted Date
2010-08-27
Last Posted Date
2013-04-01
Lead Sponsor
Eisai Co., Ltd.
Target Recruit Count
1184
Registration Number
NCT01190657
Locations
πŸ‡¨πŸ‡³

Wuhan Union Hospital, Hubei, China

πŸ‡¨πŸ‡³

Changsha Central Hospital, Hunan, China

πŸ‡¨πŸ‡³

Hunan Provincial People's Hospital, Hunan, China

and more 23 locations

A Long Term Extension Study of E2080 in Lennox-Gastaut Patients

Phase 3
Completed
Conditions
Interventions
First Posted Date
2010-06-28
Last Posted Date
2019-03-11
Lead Sponsor
Eisai Co., Ltd.
Target Recruit Count
54
Registration Number
NCT01151540

A Pilot Cross-over Bioequivalence Study of E3810 for Healthy Japanese Male (Under Postprandial Condition)

Phase 1
Completed
Conditions
Interventions
First Posted Date
2010-03-12
Last Posted Date
2013-05-13
Lead Sponsor
Eisai Co., Ltd.
Target Recruit Count
16
Registration Number
NCT01085708
Β© Copyright 2024. All Rights Reserved by MedPath